重组大肠杆菌高密度发酵研究进展

重组大肠杆菌的高密度发酵是提高基因工程产品产量的一个非常有铲的手段,是现代发酵工程研究的一个热点。本文就高密度发酵中影响重组大肠杆菌发酵产率的几个因素,包括宿主菌、培养基、培养条件、补料方法以及高密度发酵过程中存在的问题和对策加以讨论,着重探讨了高密度下大肠杆菌产生的有害代副产物－－乙酸的产生机制、抑制作用机理,以及控制乙酸机累的技术方法。     

代谢工程与重组大肠杆菌的发酵

利用代谢工程可以在重组大肠杆菌的改良中减少代谢副产物乙酸的累积,优化代谢系统,利于重组蛋白质的高表达以及重组菌的高密度发酵。应用代谢工程改良重组大肠杆菌主要包括阻断乙酸产生的主要途径、限制糖酵解途径上的碳代谢流、将过量的丙酮酸转化为其它低毒的副产物以及对碳代谢流进行分流等几个方面的工作。     

两次诱导实现重组大肠杆菌高密度、高表达研究*

通过不同温度诱导模式对大肠杆菌高密度,高表达的研究,确定两次升温诱导模式实现大肠杆菌高密度、高表达重组人载脂蛋白的目的。实验证实两次诱导成功的避免了乙酸对高密度、高表达的影响,最终发酵的细胞密度OD₆₀₀达150,蛋白表达量4.8g·L^-1,证明两次升温诱导的发酵方法在高密度、高表达外源蛋白上是成功的,从而为基因工程菌规模化生产奠定了基础。     

重组大肠杆菌YK537/pSB┐TK高密度培养过程中有机酸的RP┐HPLC快速分析

采用高压液相色谱法（ＨＰＬＣ）,利用Ｃ１８反相柱快速检测重组大肠杆菌ＹＫ５３７／ｐＳＢ－ＴＫ高密度发酵过程中细菌代谢产生的各种有机酸。分析表明,经乙醚和水两次萃取处理后能去除样品中大部分的干扰峰,可获得理想的分离效果,并能定量测出发酵过程中各种有机酸的积累。不同培养方式的结果表明用甘油代替葡萄糖作为细菌生长的碳源可减少乙酸的积累,降低其对细菌生长和外源蛋白表达的抑制作用,从而更易实现重组大肠杆菌的高表达、高密度培养。     

两次诱导实现重组大肠杆菌高密度、高表达研究

通过不同温度诱导模式对大肠杆菌高密度,高表达的研究,确定两次升温诱导模式实现大肠杆菌高密度、高表达重组人载脂蛋白的目的。实验证实两次诱导成功的避免了乙酸对高密度、高表达的影响,最终发酵的细胞密度OD600达150,蛋白表达量4.8g·L-1,证明两次升温诱导的发酵方法在高密度、高表达外源蛋白上是成功的,从而为基因工程菌规模化生产奠定了基础。     

高密度发酵重组大肠杆菌产海藻糖合成酶

酶法催化是目前生产海藻糖的主要手段。本文中,笔者通过高密度发酵重组大肠杆菌产海藻糖合成酶,进而以麦芽糖为底物,催化生产海藻糖。首先根据大肠杆菌高密度发酵条件要求,在揺瓶中对基因工程菌进行了培养基、发酵条件和诱导条件的逐一优化;然后在5 L和50 L发酵罐中进行批次补料发酵的放大实验;最后采用变指数-恒pH法的策略发酵重组大肠杆菌,结果OD_(600)达到97,海藻糖合成酶酶活达到(24 000±350) U/mL,实现了海藻糖合成酶的重组大肠杆菌高密度发酵生产,极大提高了海藻糖的生产效率。     

重组大肠杆菌产普鲁兰酶的高密度发酵工艺研究

以表达普鲁兰酶的重组大肠杆菌作为出发菌株,在摇瓶培养的基础上,建立了大肠杆菌工程菌产普鲁兰酶的高密度发酵工艺。通过测定细胞密度、细胞干重、分离菌体可溶性成分与不溶性成分及SDS-PAGE电泳,分析重组大肠杆菌的生长和普鲁兰酶的表达情况。摇瓶试验使用合成培养基和LB培养基,重组大肠杆菌在合成培养基生长较慢,诱导5 h的普鲁兰酶表达量高于LB培养基,包涵体比例低于LB培养基。重组大肠杆菌的高密度发酵使用合成培养基,补料阶段采用指数流加的工艺,在设定细胞的比生长速率为0.12的前提下,限制补料中碳源的供应,以阻止乙酸的产生。当细胞密度OD600达到70.0开始诱导,最终细胞密度为每升53.3 g细胞干重,细胞内可溶性普鲁兰酶为每升1.35 g。     

代谢副产物乙酸对L-色氨酸发酵的影响

分析了重组大肠杆菌(E.coli TRTH/pSV-709)发酵生产L-色氨酸的发酵过程,检测结果表明发酵液中有大量代谢副产物乙酸的积累。利用外源添加试验研究了乙酸对L-色氨酸发酵的影响,结果表明乙酸浓度高于2g/L时对L-色氨酸生产菌的生长和产酸均有抑制作用。分析了乙酸的产生机制,并采取了调节溶氧水平、确定合适初始葡萄糖浓度、限制葡萄糖流加及控制菌体比生长速率等措施来减少乙酸的生成。在优化条件下,乙酸含量与原工艺相比降低了51.35%,菌体生物量和L-色氨酸产量分别提高了51.07%和46.54%,实现了高密度发酵培养的目的。     

重组大肠杆菌高表达高密度发酵研究

大肠杆菌高密度高表达发酵技术是现代发酵工程的重要研究课题,此项技术可以有效地提高大肠杆菌的产量和外源重组蛋白的表达量,该文就影响大肠杆菌高密度发酵的主要因素如宿主菌类型、培养基组成、培养条件、生长抑制物质、补料调控等进行了阐述和讨论。     

可溶性TRAIL蛋白的高密度培养及补料策略研究

采用分批补料的方法高密度培养重组大肠杆菌C600/PbvTRAIL制备人可溶性TRAIL蛋白,优化发酵工艺,探索简单高效的分离纯化方法并测定蛋白生物活性。通过比较几种不同的补料策略：间歇流加、Dostat、pHstat,摸索了一种流加策略,即DOstatpHstat组合流加,有效的避免了发酵过程中,尤其是诱导表达阶段乙酸积累的增加,使TRAIL蛋白在高密度培养条件下,得到高效表达。菌体密度最终达到300g/L（WCW）以上,可溶性TRAIL蛋白占菌体总蛋白的4.2%,含量为1.1g/L。在整个发酵过程中,乙酸浓度接近于0,且未使用任何特殊手段,如纯氧、加压等,简化了发酵工艺,降低了发酵成本,为TRAIL的工业化生产创造了条件。     

Kinetics of inclusion body production in batch and high cell density fed-batch culture of Escherichia coli expressing ovine growth hormone.

A process for maximizing the volumetric productivity of recombinant ovine growth hormone (r-oGH) expressed in Escherichia coli during high cell density fermentation process has been devised. Kinetics of r-oGH expression as inclusion bodies and its effect on specific growth rates of E. coli cells were monitored during batch fermentation process. It was observed that during r-oGH expression in E. coli, the specific growth rate of the culture became an intrinsic property of the cells which reduced in a programmed manner upon induction. Nutrient feeding during protein expression phase of the fed-batch process was designed according to the reduction in specific growth rate of the culture. By feeding yeast extract along with glucose during fed-batch operation, high cell growth with very little accumulation of acetic acid was observed. Use of yeast extract helped in maintaining high specific cellular protein yield which resulted in high volumetric productivity of r-oGH. In 16 h of fed-batch fermentation, 3.2 g l-1 of r-oGH were produced at a cell OD of 124. This is the highest concentration of r-oGH reported to date using E. coli expression system. The volumetric productivity of r-oGH was 0.2 g l-1 h-1, which is also the highest value reported for any therapeutic protein using IPTG inducible expression system in a single stage fed-batch process.     

Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli

A robust high cell-density fed-batch bioprocess was developed for the heterologous production of 6-deoxyerythronolide B (6-dEB), the macrocyclic core of the antibiotic erythromycin, with a recombinant Escherichia coli strain expressing the 6-deoxyerythronolide B synthase (DEBS) from Saccharopolyspora erythraea. Initial evaluation of the E. coli strain in a 5-l bioreactor with the addition of exogenous propionate for polyketide biosynthesis resulted in a maximum cell density of 30 g l(-1) (OD600 approximately 60) and the production of 700 mg l(-1) of 6-dEB. Retention of the two plasmids harboring the heterologous genes was maintained between 90 and 100% even in the absence of antibiotic selection. However, the accumulation of excess ammonia in the culture medium was found to significantly decrease the productivity of the cells. Through optimization of the medium composition and fermentation conditions, the maximum cell density was increased by two-fold, and a final titer of 1.1 g l(-1) of 6-dEB was achieved. This represents an 11-fold improvement compared to the highest reported titer of 100 mg l(-1) with E. coli as the production host.     

Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation

The productivity of Escherichia coli as a producer of recombinant proteins is affected by its metabolic properties, especially by acetate production. Two commercially used E. coli strains, BL21 (lambdaDE3) and JM109, differ significantly in their acetate production during batch fermentation at high initial glucose concentrations. E. coli BL21 grows to an optical density (OD, 600 nm) of 100 and produces no more than 2 g/L acetate, while E. coli JM109 grows to an OD (600 nm) of 80 and produces up to 14 g/L acetate. Even in fed-batch fermentation, when glucose concentration is maintained between 0.5 and 1.0 g/L, JM109 accumulates 4 times more acetate than BL21. To investigate the difference between the two strains, metabolites and enzymes involved in carbon utilization and acetate production were analyzed (isocitrate, ATP, phosphoenolpyruvate, pyruvate, isocitrate lyase, and isocitrate dehydrogenase). The results showed that during batch fermentation isocitrate lyase activity and isocitrate concentration were higher in BL21 than in JM109, while pyruvate concentration was higher in JM109. The activation of the glyoxylate shunt pathway at high glucose concentrations is suggested as a possible explanation for the lower acetate accumulation in E. coli BL21. Metabolic flux analysis of the batch cultures supports the activity of the glyoxylate shunt in E. coli BL21.     

Influences of yeast extract on specific cellular yield of Ovine growth hormone during fed-batch fermentation of E. coli

In most cases of E. coli high cell density fermentation process, maximizing cell concentration helps in increasing the volumetric productivity of recombinant proteins usually at the cost of lower specific cellular protein yield. In this report, we describe a process for maintaining the specific cellular yield of Ovine growth hormone (oGH) from E. coli by optimal feeding of yeast extract during high cell density fermentation process. Recombinant oGH was produced as inclusion bodies in Escherichia coli. Specific cellular yield of recombinant oGH was maintained by feeding yeast extract along with glucose during fed-batch fermentation. Glucose to yeast extract ratio of 0.75 was found to be optimum for maintaining the specific cellular oGH yield of 66 mg/g of E. coli cells. Continuous feeding of yeast extract along with glucose helped in reducing acetic acid secretion and promoted higher cell growth during fed-batch fermentation. High cell growth of E. coli and high specific yield of recombinant oGH thus helped in achieving high volumetric productivity of the expressed protein. A maximum of 2 g/l of ovine growth hormone was expressed as inclusion bodies in 12 h of fed-batch fermentation.     

重组尿酸氧化酶发酵工艺优化

目的:优化并获得重组尿酸氧化酶(rUOX)基因工程大肠杆菌BL21(DE3)/pET-32a-uox高密度发酵的工艺参数。方法:在三角摇瓶中进行培养条件的优化实验,分别考察了pH值、接种量、无机盐、碳源、诱导强度等对工程菌生长和重组蛋白表达的影响,得到了优化的发酵条件;在此基础上放大至NBS BIOFLO 110 14 L发酵罐,通过对诱导时机的优化,利用分批补料发酵的方式,使rUOX在高密度培养的条件下得到高表达。结果:在优化的发酵条件下,菌体密度(D600nm)最终达到50以上,相当于20 g/L干重;可溶性rUOX占菌体总蛋白量的45%,其含量达到3.45 g/L。结论:为规模化制备重组黄曲霉尿酸氧化酶奠定了基础。     

过量表达自身hemA基因的重组大肠杆菌发酵生产5-氨基乙酰丙酸的研究

研究了优化重组大肠杆菌产5-氨基乙酰丙酸（ALA）的条件,提高大肠杆菌发酵生产AL气的产量。在测定重组大肠杆菌GT48的生长曲线的基础上,确定诱导时间,优化摇瓶发酵条件。然后,进一步在5L发酵罐上进行间歇和流加发酵研究。摇瓶实验表明,细胞培养最佳初始pH为6．5,最佳诱导时间为稳定期前期,最佳接种量为2％,过高的葡萄糖浓度对细胞生长和产物合成均有一定的抑制作用。在5L发酵罐间歇发酵中,重组菌产ALA能力达到47．8mg／L。采用流加发酵可以进一步将产物产量提高到63．8mg／L。构建的过量表达自身的hemA基因的大肠杆菌具有较高的产ALA能力,通过发酵条件优化和采用流加发酵可以提高AL气产量。     

Process and metabolic strategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B

Recently, the feasibility of using Escherichia coli for the heterologous biosynthesis of complex polyketides has been demonstrated. In this report, the development of a robust high-cell-density fed-batch procedure for the efficient production of complex polyketides is described. The effects of various physiological conditions on the productivity and titers of 6-deoxyerythronolide B (6dEB; the macrocyclic core of the antibiotic erythromycin) in recombinant cultures of E. coli were studied in shake flask cultures. The resulting data were used as a foundation to develop a high-cell-density fermentation procedure by building upon procedures reported earlier for recombinant protein production in E. coli. The fermentation strategy employed consistently produced approximately 100 mg of 6dEB per liter, whereas shake flask conditions generated between 1 and 10 mg per liter. The utility of an accessory thioesterase (TEII from Saccharopolyspora erythraea) for enhancing the productivity of 6dEB in E. coli was also demonstrated (increasing the final titer of 6dEB to 180 mg per liter). In addition to reinforcing the potential for using E. coli as a heterologous host for wild-type- and engineered-polyketide biosynthesis, the procedures described in this study may be useful for the production of secondary metabolites that are difficult to access by other routes.     

过量表达苹果酸脱氢酶对大肠杆菌NZN111产丁二酸的影响

大肠杆菌NZN111是敲除了乳酸脱氢酶的编码基因 (ldhA) 和丙酮酸-甲酸裂解酶的编码基因 (pflB) 的工程菌,厌氧条件下由于辅酶NAD(H) 的不平衡导致其丧失了代谢葡萄糖的能力。构建了苹果酸脱氢酶的重组菌大肠杆菌NZN111/pTrc99a-mdh,在厌氧摇瓶发酵过程中通过0.3 mmol/L的IPTG诱导后重组菌的苹果酸脱氢酶 (Malate dehydrogenase,MDH) 酶活较出发菌株提高了14.8倍,NADH/NAD+的比例从0.64下降到0.26,同时NAD+和NADH浓度分别